🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a first-in-human,randomized, double-blind, placebo-controlled, sing...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2018-05-23
Trial ID
NCT04169386
The individual ingredients in IQP-AK-102 have been widely used. Backed by d...
Status
Completed
Location
Udo Bongartz
Start Date
2014-01
Trial ID
NCT02041754
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled phase # clinical stu...
Status
Completed
Location
The Second Affiliated Hospital Zhejiang University School of Medicine
Start Date
2022-01-26
Trial ID
NCT05260411
This is a double-blind, randomized, placebo-controlled, multicenter study t...
Status
Completed
Location
Zhong Shan Hosipital Fu Dan University
Start Date
2020-05-13
Trial ID
NCT04358432
Treatments Being Tested
The primary cause of being overweight is an imbalance in calories consumed ...
Status
Completed
Location
Barbara Grube
Start Date
2016-05-01
Trial ID
NCT02774486
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled phase 3 clinical stu...
Status
Completed
Location
Peking University First Hospital
Start Date
2021-11-03
Trial ID
NCT05255094
This is a double-blind, randomized, placebo-controlled, multicenter study t...
Status
Completed
Location
Beijing Anzhen Hospital
Start Date
2019-11-18
Trial ID
NCT04173793
Treatments Being Tested
The individual ingredients in IQP-AK-102 have been widely used. Backed by d...
Status
Completed
Location
Barbara Grube
Start Date
2013-07
Trial ID
NCT01905956
Treatments Being Tested
This is a phase II, open-label, non-controlled, extended study. The main ob...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2019-11-04
Trial ID
NCT04173403
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled phase 3 clinical stu...
Status
Completed
Location
The Third Hospital of Nanchang
Start Date
2021-11-04
Trial ID
NCT05255458